Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.2041
+0.0101 (5.21%)
At close: Nov 4, 2026, 4:00 PM EST
0.207157
+0.0031 (1.50%)
After-hours: Nov 4, 2026, 7:41 PM EST
Context Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Selling, General & Admin | 2.44 | 2.33 | 1.96 | 1.89 | 1.93 | 2.07 | 1.79 | 1.88 | 1.7 | 1.85 | 1.63 | 1.7 | 1.83 | 2.13 | 1.74 | 1.97 | 1.99 | 2.09 | 1.8 | 0.83 |
Research & Development | 12.53 | 7.02 | 11.84 | 8.72 | 7.83 | 3.46 | 2.52 | 16.83 | 1.38 | 1.97 | 5.3 | 4.49 | 3.46 | 4.53 | 2.14 | 2.08 | 1.52 | 1.35 | 1.29 | 0.74 |
Operating Expenses | 14.97 | 9.34 | 13.8 | 10.61 | 9.76 | 5.53 | 4.31 | 18.7 | 3.09 | 3.82 | 6.93 | 6.18 | 5.29 | 6.67 | 3.88 | 4.05 | 3.51 | 3.44 | 3.09 | 1.57 |
Operating Income | -14.97 | -9.34 | -13.8 | -10.61 | -9.76 | -5.53 | -4.31 | -18.7 | -3.09 | -3.82 | -6.93 | -6.18 | -5.29 | -6.67 | -3.88 | -4.05 | -3.51 | -3.44 | -3.09 | -1.57 |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0 |
Interest & Investment Income | 0.42 | 0.52 | 0.68 | 0.83 | 0.9 | 0.96 | 0.96 | 1.24 | 0.84 | 0.15 | 0.22 | 0.29 | 0.29 | 0.36 | 0.33 | 0.19 | 0.02 | 0.01 | 0 | - |
Currency Exchange Gain (Loss) | - | 0.14 | - | - | - | -0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income (Expenses) | -0.01 | - | 0.1 | 0.08 | 0.03 | - | 0 | -0 | -0.01 | 0 | -0.06 | 0.02 | -0.01 | 0 | -0 | 0 | 0 | -0 | -0.03 | 0.03 |
EBT Excluding Unusual Items | -14.56 | -8.68 | -13.03 | -9.69 | -8.83 | -4.58 | -3.34 | -17.46 | -2.25 | -3.67 | -6.77 | -5.87 | -5.01 | -6.31 | -3.56 | -3.85 | -3.49 | -3.44 | -3.12 | -1.54 |
Other Unusual Items | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.03 | 0.1 |
Pretax Income | -14.56 | -8.68 | -13.03 | -9.69 | -8.83 | -4.58 | -3.34 | -17.46 | -2.25 | -3.67 | -6.77 | -5.87 | -5.01 | -6.31 | -3.56 | -3.85 | -3.99 | -3.44 | -3.09 | -1.44 |
Net Income | -14.56 | -8.68 | -13.03 | -9.69 | -8.83 | -4.58 | -3.34 | -17.46 | -2.25 | -3.67 | -6.77 | -5.87 | -5.01 | -6.31 | -3.56 | -3.85 | -3.99 | -3.44 | -3.09 | -1.44 |
Net Income to Common | -14.56 | -8.68 | -13.03 | -9.69 | -8.83 | -4.58 | -3.34 | -17.46 | -2.25 | -3.67 | -6.77 | -5.87 | -5.01 | -6.31 | -3.56 | -3.85 | -3.99 | -3.44 | -3.09 | -1.44 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 95 | 95 | 95 | 95 | 95 | 95 | 82 | 80 | 55 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 10 | 0 |
Shares Outstanding (Diluted) | 95 | 95 | 95 | 95 | 95 | 95 | 82 | 80 | 55 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 10 | 0 |
Shares Change (YoY) | -0.00% | -0.00% | 16.18% | 18.27% | 73.20% | 496.18% | 413.15% | 404.08% | 244.22% | - | - | - | - | - | 55.47% | 4321.91% | 4399.65% | 4471.72% | 2847.36% | 3.64% |
EPS (Basic) | -0.15 | -0.09 | -0.14 | -0.10 | -0.09 | -0.05 | -0.04 | -0.22 | -0.04 | -0.23 | -0.42 | -0.37 | -0.31 | -0.40 | -0.22 | -0.24 | -0.25 | -0.22 | -0.30 | -4.00 |
EPS (Diluted) | -0.15 | -0.09 | -0.14 | -0.10 | -0.09 | -0.05 | -0.04 | -0.22 | -0.04 | -0.23 | -0.42 | -0.37 | -0.31 | -0.40 | -0.22 | -0.24 | -0.25 | -0.22 | -0.30 | -4.00 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -7.04 | -11.47 | -8.94 | -6.58 | -5.84 | -5.06 | -4.91 | -1.94 | -3.36 | -4.36 | -7.23 | -3.46 | -4.63 | -5.73 | -3.93 | -2.99 | -2.81 | -3.86 | -4.96 | -0.04 |
Free Cash Flow Per Share | -0.07 | -0.12 | -0.09 | -0.07 | -0.06 | -0.05 | -0.06 | -0.02 | -0.06 | -0.27 | -0.45 | -0.22 | -0.29 | -0.36 | -0.25 | -0.19 | -0.18 | -0.24 | -0.48 | -0.12 |
EBITDA | -14.96 | -9.34 | -13.8 | -10.61 | -9.75 | -5.53 | -4.31 | -18.7 | -3.09 | -3.82 | -6.93 | -6.18 | -5.29 | -6.66 | -3.88 | -4.04 | -3.51 | - | - | - |
D&A For EBITDA | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
EBIT | -14.97 | -9.34 | -13.8 | -10.61 | -9.76 | -5.53 | -4.31 | -18.7 | -3.09 | -3.82 | -6.93 | -6.18 | -5.29 | -6.67 | -3.88 | -4.05 | -3.51 | -3.44 | -3.09 | -1.57 |